- Home
- TECX vs SES Comparison
TECX vs SES Comparison
Compare TECX & SES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- SES
- Stock Information
- Founded
- TECX 2019
- SES 2012
- Country
- TECX United States
- SES United States
- Employees
- TECX N/A
- SES N/A
- Industry
- TECX
- SES Auto Parts:O.E.M.
- Sector
- TECX
- SES Consumer Discretionary
- Exchange
- TECX Nasdaq
- SES Nasdaq
- Market Cap
- TECX 387.1M
- SES 384.0M
- IPO Year
- TECX 2018
- SES N/A
- Fundamental
- Price
- TECX $15.34
- SES $2.77
- Analyst Decision
- TECX Buy
- SES Buy
- Analyst Count
- TECX 6
- SES 1
- Target Price
- TECX $79.17
- SES $2.00
- AVG Volume (30 Days)
- TECX 480.8K
- SES 17.1M
- Earning Date
- TECX 11-06-2025
- SES 10-30-2025
- Dividend Yield
- TECX N/A
- SES N/A
- EPS Growth
- TECX N/A
- SES N/A
- EPS
- TECX N/A
- SES N/A
- Revenue
- TECX N/A
- SES $11,360,000.00
- Revenue This Year
- TECX N/A
- SES $883.92
- Revenue Next Year
- TECX N/A
- SES $159.98
- P/E Ratio
- TECX N/A
- SES N/A
- Revenue Growth
- TECX N/A
- SES N/A
- 52 Week Low
- TECX $13.70
- SES $0.20
- 52 Week High
- TECX $61.07
- SES $3.05
- Technical
- Relative Strength Index (RSI)
- TECX 36.96
- SES 84.63
- Support Level
- TECX $14.62
- SES $1.57
- Resistance Level
- TECX $15.47
- SES $3.05
- Average True Range (ATR)
- TECX 0.91
- SES 0.24
- MACD
- TECX 0.20
- SES 0.11
- Stochastic Oscillator
- TECX 23.04
- SES 86.75
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
About SES SES AI Corporation
SES AI Corp is a developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (Li-Metal) and Lithium-ion (Li-ion) rechargeable battery technologies for electric vehicles (EVs), Urban Air Mobility (UAM), drones, robotics, Battery Energy Storage Systems (BESS) and other applications. It includes Software and Hardware products that are EV, UAM, Drone, Molecular Universe, and Avatar.